TLR7/8 agonist 4 hydroxy-PEG10-acid
Modify Date: 2024-01-30 18:36:21
TLR7/8 agonist 4 hydroxy-PEG10-acid structure
|
Common Name | TLR7/8 agonist 4 hydroxy-PEG10-acid | ||
|---|---|---|---|---|
| CAS Number | 2388520-17-8 | Molecular Weight | 837.01 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C41H68N6O12 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TLR7/8 agonist 4 hydroxy-PEG10-acidTLR7/8 agonist 4 hydroxy-PEG10-acid (compound 9) is a drug-linker conjugate for ADC with potent antitumor activity by using TLR7/8 agonist 4 (HY-139018; a TLR7/8 agonist), linked via the cleavable ADC linker hydroxy-PEG10-acid (HY-133307)[1]. |
| Name | TLR7/8 agonist 4 hydroxy-PEG10-acid |
|---|
| Description | TLR7/8 agonist 4 hydroxy-PEG10-acid (compound 9) is a drug-linker conjugate for ADC with potent antitumor activity by using TLR7/8 agonist 4 (HY-139018; a TLR7/8 agonist), linked via the cleavable ADC linker hydroxy-PEG10-acid (HY-133307)[1]. |
|---|---|
| Related Catalog | |
| Target |
Traditional Cytotoxic Agents |
| In Vitro | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. |
| References |
[1]. Shelley Erin ACKERMAN, et al. Immunoconjugates targeting her2. WO2020190725A1. |
| Molecular Formula | C41H68N6O12 |
|---|---|
| Molecular Weight | 837.01 |